I-MAB (IMAB)
1.66
-0.08
(-4.60%)
USD |
NASDAQ |
May 31, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
I-MAB Shareholders Equity (Quarterly): 242.38M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 242.38M |
June 30, 2023 | 337.31M |
June 30, 2023 | 337.31M |
December 31, 2022 | 421.77M |
June 30, 2022 | 599.25M |
June 30, 2022 | 599.25M |
December 31, 2021 | 715.33M |
June 30, 2021 | 844.49M |
June 30, 2021 | 844.49M |
Date | Value |
---|---|
December 31, 2020 | 861.30M |
September 30, 2020 | 548.10M |
June 30, 2020 | 240.28M |
June 30, 2020 | 240.28M |
December 31, 2019 | -290.80M |
September 30, 2019 | 181.08M |
June 30, 2019 | -210.69M |
June 30, 2019 | -210.69M |
December 31, 2018 | -138.84M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-290.80M
Minimum
Dec 2019
861.30M
Maximum
Dec 2020
370.61M
Average
337.31M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
Verastem Inc | 46.22M |
Summit Therapeutics Inc | 44.21M |
CEL-SCI Corp | 14.30M |
AIM ImmunoTech Inc | 4.826M |
IGC Pharma Inc | 9.053M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 368.62M |
Total Liabilities (Quarterly) | 126.23M |
Debt to Equity Ratio | 0.0517 |
Current Ratio | 5.674 |
Net Debt Paydown Yield | -2.73% |